Skip to main content
. Author manuscript; available in PMC: 2019 Nov 18.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2017 Jul 27;26(10):1511–1518. doi: 10.1158/1055-9965.EPI-17-0290

Table 2.

Age-adjusted incidence rates of ovarian and fallopian tube cancer by histology subtype and race, SEER, 2000–2013

Histology Race N Ratea Ratea 95% CI Ratea ratio Ratea ratio 95% CI Ratea ratio P value
All histologies NHW 57,366 13.12 13.01–13.23 1.00 Referent
NHB 5,814 9.30 9.06–9.54 0.71 0.69–0.73 <0.0001
Hispanic 7,901 10.35 10.12–10.59 0.79 0.77–0.81 <0.0001
Asian 5,160 9.11 8.86–9.36 0.69 0.67–0.71 <0.0001
Serous NHW 35,593 8.11 8.03–8.20 1.00 Referent
NHB 3,563 5.69 5.50–5.88 0.70 0.68–0.73 <0.0001
Hispanic 4,594 6.09 5.90–6.27 0.75 0.73–0.77 <0.0001
Asian 2,601 4.62 4.44–4.8O 0.57 0.55–0.59 <0.0001
Clear Cell NHW 2,570 0.62 0.59–0.64 1.00 Referent
NHB 141 0.21 0.18–0.25 0.35 0.29–0.41 <0.0001
Hispanic 354 0.41 0.37–0.46 0.67 0.59–0.75 <0.0001
Asian 602 1.02 0.94–1.10 1.65 1.50–1.80 <0.0001
Endometrioid NHW 4,718 1.15 1.11–1.18 1.00 Referent
NHB 339 0.52 0.47–0.58 0.45 0.40–0.51 <0.0001
Hispanic 761 0.91 0.84–0.98 0.79 0.73–0.86 <0.0001
Asian 566 0.97 0.89–1.05 0.84 0.77–0.92 0.0001
Carcinosarcoma NHW 1,715 0.39 0.37–0.41 1.00 Referent
NHB 174 0.28 0.24–0.33 0.73 0.62–0.86 0.0001
Hispanic 203 0.29 0.25–0.33 0.74 0.63–0.86 <0.0001
Asian 120 0.21 0.18–0.25 0.55 0.45–0.66 <0.0001
Mucinious NHW 2,899 0.73 0.70–0.75 1.00 Referent
NHB 364 0.56 0.50–0.62 0.77 0.69–0.86 <0.0001
Hispanic 580 0.68 0.62–0.74 0.93 0.85–1.02 0.1445
Asian 423 0.73 0.66–0.80 1.01 0.90–1.11 0.9383
Other/NOSb NHW 9,871 2.13 2.08–2.17 1.00 Referent
NHB 1,233 2.03 1.92–2.15 0.96 0.90–1.01 0.1364
Hispanic 1,409 1.99 1.88–2.10 0.93 0.88–0.99 0.0213
Asian 848 1.56 1.46–1.67 0.74 0.68–0.79 <0.0001

Abbreviation: NOS, not otherwise specified.

a

Rates are per 100,000 and age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25–1130) standard; CIs (Tiwari mod) are 95% for rates and ratios.

b

Include mixed, other, undifferentiated, unspecified carcinoma.